Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
evoxx technologies
Monheim am Rhein, North Rhine-Westphalia, Germanyevoxx.com ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Commercial
01
Overview
evoxx technologies, via proprietary directed evolution and metagenome technologies, develops and commercially manufactures custom enzymes and probiotics for food, nutrition, and industrial applications, now as part of Advanced Enzymes Technologies Ltd. The technologies enable rapid translation from enzyme design to production, and products are used globally in both healthcare and food sectors.
- Therapeutic areas
- Metabolic DisordersGastroenterologyOther
- Modalities
- Recombinant proteinRecombinant proteaseEnzyme replacement therapyProbioticBiologic
- Industry
- Non-Drug Biotech
02
Partnerships
Symrise Cosmetic Ingredients
Beyond the preview
Go deeper on evoxx technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on evoxx technologies.